https://www.healio.com/news/rheumatology/20230220/guselkumabs-safety-profile-consistent-regardless-tnfinhibitor-use-in-psoriatic-arthritis
0
0
2/20/23 at 9:39pm
Organization
Healio
Authors
The 2-year safety profile of guselkumab appears consistently favorable across patients with psoriatic arthritis who are either naïve or experienced with TNF inhibitors, according to data published by The Journal of Rheumatology. “Guselkumab, a monoclona…
Create an account
or login to join the discussion